The xanthine oxidase (XO)-inhibitory activity of aqueous and organic extracts of 27 selected species belonging in five genera (Fallopia, Oxyria, Persicaria, Polygonum and Rumex) and P. viviparum demonstrated the highest XO-inhibitory activity (> 85% inhibition) at 400 µg/mL. The IC 50 values of the active extracts were also determined. On the basis of the results, these plants, and especially P. hydropiper and R. acetosella, are considered worthy of activity-guided phytochemical investigations.
INTRODUCTION
Xanthine oxidase (XO), an enzyme present in significant concentrations in the gastrointestinal tract and liver, is responsible for the metabolism of hypoxanthine and xanthine to uric acid in the purine catabolic pathway, yielding superoxide radicals. XO is an important biological source of O 2
•-and has been reported in various pathological processes; it plays a crucial role in various forms of ischaemic and other types of tissue and vascular injuries, inflammatory diseases, stroke, diabetes mellitus, rheumatic disease, liver disorders, renal failure and chronic heart failure (Parks et al., 1983; Harrison, 2002) . Moreover, excessive levels of uric acid in the blood, i.e.
hyperuricaemia, cause gout. XO inhibitors are able to hinder the synthesis of uric acid in the organism and, as anti-inflammatory agents, can alleviate the symptoms of inflammatory associated diseases (Liu et al., 2008) . In clinical practice, only allopurinol is used to inhibit the enzyme, in the treatment and prevention of gout, but it can cause a number of adverse side-effects, such as allergic and hypersensitivity reactions, gastrointestinal distress, nephropathy, skin rash and enhancement of 6-mercaptopurine toxicity (Pacher et al., 2006) . The development of new hypouricaemic agents with greater effectiveness and a better safety profile is therefore highly desirable.
In recent years, a number of research groups have commenced explorations of potencial XO inhibitors from a wide variety of traditional folk medicines. Numerous studies have dealt with investigations of the XO-inhibitory activities of plant extracts used in certain countries for the treatment of hyperuricaemia, and especially gout (Owen et al., 1999; Kong et al., 2000) . Among the natural compounds that have been tested, the flavonoids have attracted considerable attention, and structure-activity relationship studies have been performed (Cos et al., 1998) .
As a continuation of our screening programme relating to plants and bioactive natural compounds in the flora of the Carpathian Basin (Réthy et al., 2007; CsuporLöffler et al., 2009; Lajter et al., 2013 , Ványolós et al., 2014 and Rumex acetosa) and in folk medicine. Rhubarb (Rheum palmatum) is a well-known medicinal plant of the family; it has been used as a laxative for centuries. P. cuspidatum has been utilized in traditional Asian medicine as a diuretic agent (Mazid et al., 2009) .
The leaves of R. nepalensis have found use in traditional medicine for the treatment of injury caused by stinging nettles and against colic and syphilic ulcers (Gautam et al., 2010) . Its roots are used to cure dysentery. Fallopia species are traditionally utilized in Asia for the treatment of inflammation, hepatitis, osteomyelitis, gallstone and skin burn (Hromádková et al., 2010) . Polygonum cognatum, Rheum ribes and Rumex acetosella have been applied for the treatment of urinary inflammation and as diuretic agents in Turkish ethnomedicine (Cakilcioglu et al., 2010) .
The H 2 O extract of P. cuspidatum rhizome has been reported to display noteworthy XO-inhibitory activity (IC 50 = 38 μg/mL). In analogous tests, neither the MeOH nor the H 2 O extract of P. aviculare (whole plant) or R. palmatum (rhizome) exerted any activity (Kong et al., 2000) .
The most characteristic compounds identified in the species of the Polygonaceae family are phenolic compounds (e.g. anthraquinones, flavonoids, naphthalenes, stilbenes and tannins), terpenoids and polysaccharides (Hegnauer, 1990; Demirezer et al., 2001) . In some cases, drimane sesqui-and norsesquiterpenoids and sulfated flavonoids have also been isolated from Polygonum species (Fukuyama et al., 1982; Yagi et al., 1994) .
Polygonaceae species are rich sources of bioactive constituents which contribute to a wide range of medicinal properties. Stilbene derivatives (e.g. resveratrol and piceid) with antimicrobial and antioxidant activities have been isolated from Polygonaceae species (Shan et al., 2008) . Flavonoids and chalcones of P. hydropiper exhibit strong antioxidant effects, and play an important role against pathologic processes that give rise to oxidative stress, such as arteriosclerosis or cancer (Yagi et al., 1994) . The widely used medicinal plant R. palmatum contains anthranoids (e.g. emodin, aloe-emodin and physcion) as main active constituents. Their pharmacological activities have been investigated in many assays. Aloe-emodin has been reported to induce the apoptosis of hepatocellular carcinoma cells (Jeon et al., 2012) . Emodin has been investigated for its antidiabetic and antitumour activity (Xue et al., 2010; Hsu et al., 2012) , and for its lipid-lowering and neuroprotective effects in rat cortical neurons Mishra et al., 2014) . Quercetin and its derivatives, isolated from many plants of this family, are used widely as standards in XO-inhibitory assays because of their strong activities (Lee et al., 2008) .
MATERIALS AND METHODS
Plant materials. Plants were collected in several regions of the Carpathian Basin Preparation of the extracts. Extracts were prepared from 10 g of air-dried, powdered plant material with 100 mL of MeOH with the use of an ultrasonic bath (3 × 15 min).
After filtration, the solutions were evaporated to dryness under reduced pressure. The residues were dissolved in 50 mL of 50% aqueous MeOH and were subjected to solvent-solvent partition between n-hexane (3 × 50 mL) (extracts A) and CHCl 3 (3 × 50 mL) (extracts B); and the residual 50% MeOH extracts were named extracts C. After the extraction with MeOH, the residual plant materials were dried and extracted with 30 mL of boiling H 2 O for 15 min. The filtered extracts were freeze-dried, affording extracts D. The yields (w/w) of the extracts are shown in Table 1 .
Xanthine oxidase assay. The method is based on a modified protocol of Sigma, a continuous spectrophotometric rate determination: the absorbance of XO-induced uric acid production from xanthine was measured at 290 nm for 3 min in a 96-well plate, using the plate reader FluoSTAR OPTIMA (BMG LABTECH). The XO-inhibitory effect was determined via the decreased production of uric acid. Reagents: 50 mM potassium phosphate buffer, pH 7.5 with 1 M KOH, 0.15 mM xanthine solution (pH 
RESULTS AND DISCUSSION
In the course of our screening study, the XO-inhibitory activities of 27 species of the Polygonaceae family [Fallopia (3), Oxyria (1), Persicaria (2), Polygonum (8) and
Rumex (13) Persicaria hydropiper) (Yagi et al., 1994) ; it can be supposed that such compounds are responsible for the XO inhibitory activity. and 27.3 μg/mL) exhibited high activity against XO. Some of them are applied traditionally as an anti-inflammatory, diuretic and anticancer agent (Rao et al., 2011) .
In view of the pronounced XO-inhibitory activity of the appreciable number of investigated species, they are worthy of further investigations, including bioassayguided isolation and identification of the active substances. Earlier publications on the highly active R. acetosella indicated the presence of phenolic compounds and its antioxidant capacity, but its XO-inhibitory activity has not been investigated previously (Özen, 2010) . However, the ability of inhibiting XO is strongly connected with the antioxidant capacity, since reactive oxygen species are produced during the formation of uric acid in the presence of XO. Hence, the results of the investigations of the radicalscavenging activity or the reducing power of the plants suggest the XO-inhibition potency of the plants and their compounds (Maksimovic et al., 2011) .
In summary, the present paper reports for the first time a systematic comprehensive study on the XO-inhibitory activity of Polygonaceae species native to the Carpathian-basin, including 27 species of Fallopia, Oxyria, Persicaria, Polygonum and Rumex genera. The in vitro screen has provided important preliminary data promoting the selection of Polygonaceae species (native to the Carpathian Basin) and their different extracts with potential anti-hyperuricaemic properties for future work.
These species, and especially P. hydropiper, R. acetosella, R. alpinus, R.
conglomeratus, R. hydrolapathum, R. patientia and R. stenophyllus, are promising candidates for further activity-guided fractionation in the search for new active XOinhibitory natural compounds. 
